BRAF peptide vaccine facilitates therapy of murine BRAF-mutant melanoma

Liu, Q; Zhu, HD; Liu, Y; Musetti, S; Huang, L

Huang, L (reprint author), Univ N Carolina, Eshelman Sch Pharm, Div Pharmacoengn & Mol Pharmaceut, 1315 Kerr Hall,Campus Box 7571, Chapel Hill, NC 27599 USA.; Huang, L (reprint author), Univ N Carolina, Eshelman Sch Pharm, Ctr Nanotechnol Drug Delivery, 1

CANCER IMMUNOLOGY IMMUNOTHERAPY, 2018; 67 (2): 299

Abstract

Approximately, 50% of human melanomas are driven by BRAF mutations, which produce tumors that are highly immunosuppressive and often resistant to vacc......

Full Text Link